ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
AC Immune SA

AC Immune SA (ACIU)

2.73
0.00
(0.00%)
Closed 30 December 8:00AM
0.00
0.00
(0.00%)

AC Immune SA Financial Summary

The current ACIU market cap is 270.81M. The company's latest EPS is CHF -0.5467 and P/E is -4.99.

Quarter End
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Revenue
Operating Income
Net Income
Year End 31 December 2023 20192020202120222023
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Revenue 111.03M15.43M03.94M14.8M
Operating Income 44.54M-61.26M-79.01M-70.85M-53.62M
Net Income 45.44M-61.92M-73M-70.75M-54.23M
Quarter End
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Assets
Total Liabilities
Total Equity
Year End 31 December 2023 20192020202120222023
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Total Assets 299.25M238.74M261.44M185.94M182.81M
Total Liabilities 26.81M23.26M29.46M16.95M22.17M
Total Equity 272.44M215.48M231.98M168.99M160.64M
Quarter End
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Operating
Investing
Financing
Year End 31 December 2023 20192020202120222023
CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)CHF (CHF)
Operating 55.22M-59.52M-65.69M-73.57M-60.41M
Investing -66.89M28.33M-53.66M23.76M65.65M
Financing 49.62M-803k40.75M-1.35M43.25M
Market Cap 270.81M
Price to Earnings Ratio -4.99
Price to Sales Ratio 18.3
Price to Cash Ratio 3.45
Price to Book Ratio 1.69
Dividend Yield -

Share Statistics

Shares Outstanding 99.2M
Average Volume (1 week) 166.59k
Average Volume (1 Month) 154.23k
52 Week Change -44.96%
52 Week High 5.04
52 Week Low 2.25
Spread (Intraday) 0.35 (11.48%)

Company Info

Company Name AC Immune SA
Address epfl innovation park
lausanne 1015
Website https://www.acimmune.com
Industry pharmaceutical preparations (2834)